Source: International Congress 2014 – Therapy of thoracic tumours: clinical trials and case series
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
Y. Ragulin, I. Khvostunov, L. Kursova, N. Shepel, D. Glazyrin, I. Gulidov (Obninsk, Russian Federation). Biological dosimetry in lung cancer (LC) patients treated with fractionated radiotherapy (RT). Eur Respir J 2014; 44: Suppl. 58, 2716

Member's Comments

No comment yet.

Related content which might interest you: Site of first progression (PR) differs between stage III NSCLC patients treated with simultaneous radiochemotherapy (RTCT) and those treated with radiotherapy (RT) alone following induction chemotherapy (CT) Source: International Congress 2014 – Advances in diagnosis and therapy of thoracic tumours Year: 2014 Stereotactic ablative radiotherapy (SABR) in non-surgical non small cell lung cancer: Effects on respiratory function Source: International Congress 2014 – Therapy of thoracic tumours: clinical trials and case series Year: 2014 Gene therapy with DDMC-p53 with or without cisplatin and microwave ablation. A future concept for local treatment in lung cancer Source: International Congress 2015 – Diagnosis and therapy of lung cancer Year: 2015 Maintenance therapy with pemetrexed in non-small-cell lung cancer: Impact on survival Source: International Congress 2015 – Lung cancer therapy: clinical trials Year: 2015 Our results of stereotactic radiotherapy in advanced stage lung cancer patients Source: International Congress 2014 – Therapy of thoracic tumours: clinical trials and case series Year: 2014 Surgical treatment outcomes on early-stages of non-small-cell lung cancer Source: International Congress 2015 – Diagnosis and therapy of lung cancer Year: 2015 Survival in lung cancer: Associated factors in Tunisian patients Source: International Congress 2015 – Thoracic oncology around the world: rare cases and local features Year: 2015 Safety and efficacy of erlotinib in patients with squamous cell lung cancer Source: International Congress 2014 – Therapy of thoracic tumours: clinical trials and case series Year: 2014 Impact of second-line treatment on overall survival of advanced lung adenocarcinoma patients Source: International Congress 2016 – Lung cancer: therapeutic modalities, re-staging, and follow-up Year: 2016 Muldisciplinary conference (MDC), oncological program (OP) and practice guidelines (GL): The experience of the lung cancer (LC) clinic of a cancer hospital Source: International Congress 2014 – Advances in diagnosis and therapy of thoracic tumours Year: 2014 Brain metastatic recurrence following radically treated lung cancer; a retrospective analysis Source: International Congress 2014 – Therapy of thoracic tumours: clinical trials and case series Year: 2014 Electrospray-mediated local chemotherapy of lung carcinoma in mice Source: International Congress 2016 – Basic science and case reports in lung cancer Year: 2016 EBUS-TBNA for nodal restaging and relapse in lung cancer Source: International Congress 2014 – Diagnosis, imaging and surgery for thoracic tumours Year: 2014 International trial of endobronchial implantation of electromagnetic fiducials for real-time tracking of lung tumors during radiotherapy (RT) Source: Annual Congress 2013 –Interventional procedures for diagnosis of diffuse lung diseases and peripheral pulmonary lesions Year: 2013 Algorithm of preoperative N-staging of non-small cell lung cancer Source: Annual Congress 2013 –Oncological thoracic surgery Year: 2013 Role of mean sUV and metabolic tumor volume by PET/CT for determination of mean survival time in patients with non-small cell lung cancer Source: International Congress 2014 – Improving diagnosis of thoracic tumours Year: 2014 Primary lung cancer treated using radiofrequency ablation: Two year outcome data Source: International Congress 2014 – Therapy of thoracic tumours: clinical trials and case series Year: 2014 Pemetrexed in maintenance therapy of 164 patients with advanced non-small-cell lung cancer (NSCLC) Source: International Congress 2016 – Lung cancer: therapeutic modalities, re-staging, and follow-up Year: 2016 Influence of neoadjuvant therapy to complication rate after surgery for primary lung cancer Source: International Congress 2016 – Surgical strategy for complex diseases Year: 2016 Metronomic chemotherapy in human lung cancer: Mathematical modeling for an optimal schedule Source: International Congress 2015 – Lung cancer therapy: clinical trials Year: 2015